Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Grwth 3 Regulatory News (MIG3)

Share Price Information for Maven Grwth 3 (MIG3)

Share Price is delayed by 15 minutes
Get Live Data
43.80    0.00 (0.00%)
Bid:
42.80
Ask:
44.80
Spread: 2.00 (4.673%)
Market Cap: £68.37m
MIG3 Live PriceLast checked at - London Stock Exchange

Intraday Maven Grwth 3 Share Chart

Director/PDMR Shareholding

6 Apr 2011 14:28

RNS Number : 4275E
Maven Income and Growth VCT 3 PLC
06 April 2011
 



MAVEN INCOME AND GROWTH VCT 3 PLC

 

Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons

 

1. Name of the issuer

 

MAVEN INCOME AND GROWTH VCT 3 PLC

 

2. State whether the notification relates to (i) a transaction notified in accordance with DTR 3.1.2 R, (ii) a disclosure made in accordance with LR 9.8.6R(1) or (iii) a disclosure made in accordance with section 793 of the Companies Act (2006).

 

DTR 3.1.2.R

 

3. Name of person discharging managerial responsibilities/director

 

WILLIAM ROBERT NIXON

 

4. State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person

 

CONNECTED PERSON: MAVEN CAPITAL PARTNERS UK LLP

 

5. Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest

 

NON-BENEFICIAL INTEREST

 

 6. Description of shares (including class), debentures or derivatives or financial instruments relating to shares

 

ORDINARY 10P SHARES

 

7. Name of registered shareholders(s) and, if more than one, the number of shares held by each of them

 

MAVEN CAPITAL PARTNERS UK LLP NOMINEE ACCOUNT

 

 8. State the nature of the transaction

 

 PURCHASE

 

9. Number of shares, debentures or financial instruments relating to shares acquired

 

 75,000

 

10. Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)

 

0.25%

 

11. Number of shares, debentures or financial instruments relating to shares disposed

 

 NONE

 

12. Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)

 

 NONE

 

13. Price per share or value of transaction

 

 50.00P PER SHARE

 

 14. Date and place of transaction

 

 6 APRIL 2011 LONDON

 

15. Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)

 

265,358; 0.87%

 

16. Date issuer informed of transaction

 

6 APRIL 2011

 

Name of contact and telephone number for queries

 

DAVID RUSSELL (TEL: 0141 206 0107)

 

Name of authorised official of issuer responsible for making notification

 

MAVEN CAPITAL PARTNERS UK LLP, SECRETARY

 

Date of notification

 

6 APRIL 2011

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSXQLFBFZFLBBV
Date   Source Headline
20th May 202610:00 amRNSAdmission of Further Securities to Trading
15th May 202610:05 amRNSIssue of Equity - Dividend Investment Scheme
12th May 20263:35 pmRNSUnaudited NAV - Dividend Investment Scheme
8th May 20267:00 amRNSTransaction in Own Shares
30th Apr 20261:30 pmRNSResult of AGM
30th Apr 202610:54 amRNSAdmission of Further Securities to Trading
29th Apr 202612:28 pmRNSIssue of Equity
20th Apr 202612:23 pmRNSPublication of a Supplementary Prospectus
15th Apr 202611:19 amRNSAdmission of Further Securities to Trading
14th Apr 202611:07 amRNSIssue of Equity
8th Apr 20269:28 amRNSAdmission of Further Securities to Trading
25th Mar 202610:54 amRNSAdmission of Further Securities to Trading
24th Mar 20265:32 pmRNSAnnual Financial Report
24th Mar 202612:11 pmRNSIssue of Equity
17th Mar 20264:36 pmRNSNet Asset Value(s)
27th Feb 20265:01 pmRNSTransaction in Own Shares
27th Feb 20267:00 amRNSUnaudited NAV and Dividend Declaration
18th Feb 20264:52 pmRNSAdmission of Further Securities to Trading
17th Feb 202611:05 amRNSDirector/PDMR Shareholding
17th Feb 202611:02 amRNSDirector/PDMR Shareholding
17th Feb 202611:02 amRNSDirector/PDMR Shareholding
17th Feb 202611:00 amRNSDirector/PDMR Shareholding
17th Feb 202610:55 amRNSIssue of Equity
4th Feb 20267:00 amRNSStatement re Offer for Subscription
21st Jan 202611:03 amRNSAdmission of Further Securities to Trading
16th Jan 20269:42 amRNSIssue of Equity
14th Jan 20262:35 pmRNSUnaudited NAV - Dividend Investment Scheme
16th Dec 202510:20 amRNSIssue of Equity
4th Dec 202510:35 amRNSUnaudited NAV and Second Interim Dividend
13th Nov 20254:47 pmRNSResult of General Meeting
28th Oct 20254:24 pmRNSTransaction in Own Shares
2nd Oct 20254:42 pmRNSPublication of a Prospectus
15th Sep 20251:08 pmRNSNet Asset Value(s)
29th Aug 20257:00 amRNSIssue of Equity
20th Aug 20252:13 pmRNSStatement re Dividend Investment Scheme
23rd Jul 20254:30 pmRNSHalf-year Report
22nd Jul 20254:49 pmRNSTransaction in Own Shares
16th Jul 20257:08 amRNSStatement re Offer for Subscription
10th Jul 20254:46 pmRNSStatement re Unaudited NAV and Interim Dividend
15th May 20253:57 pmRNSTransaction in Own Shares
9th May 20259:54 amRNSDirector/PDMR Shareholding
9th May 20259:51 amRNSIssue of Equity
6th May 202511:53 amRNSIssue of Equity
2nd May 20251:11 pmRNSAudited NAV - Dividend Investment Scheme
1st May 20253:15 pmRNSResult of AGM
17th Apr 202512:56 pmRNSPublication of Suppl.Prospcts
7th Apr 20257:00 amRNSIssue of Equity - Replacement
4th Apr 20256:17 pmRNSIssue of Equity
1st Apr 202512:59 pmRNSStatement re Offers for Subscription - Closed
27th Mar 20251:11 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.